TNF and lymphoma: The risk of lymphoma was significantly higher among patients exposed to combination therapy (HR 6.11) than in those exposed to thiopurine monotherapy (HR: 2.60) or anti-TNF monotherapy (HR: 2.41) compared to unexposed patients [77].